During the past decade, Grupo Angeles conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 10 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grupo Angeles" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "German Breast Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Grupo Angeles" are "Breast Cancer" (6 trials), "Non-Small Cell Lung Cancer" (2 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Grupo Angeles" in a lesser frequency.

Most popular intervention types in "Grupo Angeles" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Docetaxel" (5 trials), "Pertuzumab" (5 trials), "Trastuzumab" (5 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Grupo Angeles" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Grupo Angeles". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Grupo Angeles, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Grupo Angeles, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".